Delattre, Jean-Yves

Clinical trial of blood-brain barrier disruption by pulsed ultrasound

Carpentier, A., Canney, M., Vignot, A., Reina, V., Beccaria, K., Horodyckid, C., Karachi, C., Leclercq, D., Lafon, C., Chapelon, J.-Y., et al. (2016) · Science Translational Medicine

Ultrasound and Hyperthermia ApplicationsBarrier Structure and Function Studies

Cited by 757

Neurological complications of radiotherapy and chemotherapy

Keime-Guibert, F., Napolitano, M., & Delattre, J.-Y. (1998) · Journal of Neurology

Cancer-related cognitive impairment studiesBrain Metastases and Treatment

Cited by 246

PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas

Appay, R., Dehais, C., Colin, C., Alentorn, A., Carpentier, C., Ducray, F., Ibdaih, A., Kamoun, A., Mokhtari, K., Tabouret, E., et al. (2019) · Neuro-Oncology

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 126

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2 -Amplified and TP53 Wild-type Glioblastomas

Verreault, M., Schmitt, C., Goldwirt, L., Pelton, K., Haidar, S., Levasseur, C., Guehennec, J., Knoff, D., Labussière, M., Marie, Y., et al. (2016) · Clinical Cancer Research

Cancer-related Molecular PathwaysGlioma Diagnosis and Treatment

Cited by 114

The multidimensional burden of informal caregivers in primary malignant brain tumor

Bayen, E., Laigle-Donadey, F., Prouté, M., Hoang-Xuan, K., Joël, M.-E., & Delattre, J.-Y. (2017) · Supportive Care in Cancer

Nursing care and researchCancer survivorship and care

Cited by 82

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Forest, F., Maurage, C.-A., Vignaud, J.-M., et al. (2014) · Neuro-Oncology

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 63